Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes
- 1 April 2018
- journal article
- review article
- Published by Elsevier in Genetics in Medicine
- Vol. 20 (4) , 383-389
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologiesGenetics in Medicine, 2013
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- HFE Cys282Tyr Homozygotes With Serum Ferritin Concentrations Below 1000 μg/L Are at Low Risk of Hemochromatosis†,‡Hepatology, 2010
- Population Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and EthicsPublic Health Genomics, 2009
- HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein CholesterolCirculation: Cardiovascular Genetics, 2009
- Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relativesGenetics in Medicine, 2009
- HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) StudyTranslational Research, 2008
- Hemochromatosis and Iron-Overload Screening in a Racially Diverse PopulationNew England Journal of Medicine, 2005
- Evolution of Untreated Hereditary Hemochromatosis in the Busselton Population: A 17-Year StudyMayo Clinic Proceedings, 2004
- A Population-Based Study of the Clinical Expression of the Hemochromatosis GeneNew England Journal of Medicine, 1999